Companion Testing Technologies Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — built from company filings, government statistics and trade data, and structured for confident strategic decision-making. Request a free report preview to see its scope, chapters and methodology before you buy.
Market Snapshot
2025 Market Size
US$ 684.1 million
Estimated Base Value
2035 Forecast
US$ 1.7 billion
Projected Market Value
CAGR 2026–2035
9.5%
Compound Annual Growth
Largest Segment
Point-of-Care Diagnostic Tests
Fastest Growing Segment
Electric Commercial Vehicles
Leading Region
North America
Fastest Growing Region
Asia Pacific
Top Country
United States
By Market Share
Largest market
Key Players
Heska
Emerging Players
Zoetis, PetDx
Companion Testing Technologies Market Overview
The Companion Testing Technologies Market provides diagnostic solutions for companion animals such as dogs, cats, and horses. It covers the development, manufacturing, and commercialization of medical devices and diagnostic tools used for disease detection, diagnosis, monitoring, and screening. These technologies range from rapid point-of-care tests and in-clinic analyzers for various parameters like hematology and clinical chemistry, to advanced molecular diagnostics conducted in reference laboratories. The primary purchasers are veterinary professionals, including those in veterinary reference laboratories, hospitals, clinics, and academic institutions, who utilize these tools to improve animal health outcomes through accurate and timely disease identification, supporting treatment decisions and preventative care.
The Companion Testing Technologies Market is estimated at $684.1 Mn in 2025 and is forecast to reach $1.7 Bn in 2035, growing at a CAGR of 9.5% from 2025 to 2035. Demand is driven by factors such as rising pet humanization, increased pet ownership globally, and growing awareness among pet owners regarding preventative care. Advancements in veterinary diagnostic technologies also contribute to market expansion. However, high costs associated with advanced tests and a lack of awareness among some pet owners act as restraints, limiting broader adoption and market growth.
The market is segmented by Type (Point-Of-Care Diagnostic Tests, In-House Laboratory Analyzers, Molecular Diagnostic Platforms, Reference Laboratory Services, Diagnostic Imaging Modalities, Anatomical Pathology Services, Data Management & Software Solutions), Technology (Immunoassay, Molecular Diagnostics, Clinical Chemistry, Hematology, Urinalysis, Radiography, Ultrasonography, Cytology & Histopathology Techniques), Application (Infectious Disease Diagnosis, Parasitic Disease Diagnosis, Allergy & Dermatology Testing, Cancer & Oncology Diagnostics, Endocrine System Testing, Renal & Hepatic Function Monitoring, Genetic Health Screening, Pre-Surgical Screening & Wellness Panels), End-User (Veterinary Reference Laboratories, Veterinary Hospitals & Clinics, Academic Veterinary Institutes, Animal Welfare Organizations & Shelters, Specialty Veterinary Practices, Pharmaceutical & Animal Health Companies, Private Diagnostic Laboratories), Component (Diagnostic Instruments, Reagents & Assays, Consumables & Disposables, Software & Informatics, Service & Support), and Deployment (Centralized Laboratory Deployment, In-Clinic Benchtop Deployment, Point-Of-Care Mobile Deployment, Cloud-Based Software Deployment, On-Premise Software Deployment). It is served across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Leading companies include Heska, Virbac, Neogen Corporation, Bio-Rad Laboratories, Horiba, Sysmex, Biomerieux, Mindray, Ceva Sante Animale, Randox Laboratories, DiaSys Diagnostic Systems, and Eurofins Scientific. The full report covers market size, growth drivers, restraints, opportunities, and competitive landscape.
Market Definition & Overview
The Companion Testing Technologies Market encompasses the development, manufacturing, and commercialization of advanced medical devices and diagnostic solutions specifically engineered for the detection, diagnosis, monitoring, and screening of diseases and health conditions in companion animals, including dogs, cats, and horses. This market provides essential tools for veterinary professionals, ranging from point-of-care rapid tests and in-clinic analyzers for hematology, clinical chemistry, and immunology, to sophisticated molecular diagnostics performed in reference laboratories. It aims to improve animal health outcomes through accurate and timely disease identification, guiding effective treatment decisions and preventative care strategies for pets.
Scope
- Global market coverage across all key regions
- Exclusive focus on companion animal species (e.g., dogs, cats, horses)
- Analysis period spanning from 2025 to 2035
Inclusions
- In-vitro diagnostic instruments for companion animal health
- Point-of-care (POC) diagnostic test kits and consumables
- Clinical chemistry and hematology analyzers for veterinary use
- Immunodiagnostic assays and reagents for companion animals
- Molecular diagnostic systems (e.g., PCR, DNA sequencing) for pets
- Pathology and cytology testing equipment and services
Exclusions
- Companion animal pharmaceuticals and vaccines
- Surgical instruments and therapeutic medical devices
- Diagnostic technologies for livestock and production animals
- Human-specific medical diagnostic products
- General veterinary imaging equipment (e.g., X-ray, MRI, CT)
Market Size Forecast
Executive Summary
• The Companion Testing Technologies market is valued at $684.1 Mn in 2025 and is forecast to reach $1.7 Bn by 2035, reflecting a robust CAGR of 9.5% as demand accelerates across every major segment and region over the ten-year outlook.
• Point-of-Care Diagnostic Tests leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• North America commands the largest regional share at XX.X%, while Asia Pacific is expanding the fastest at a XX.X% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at XX.X% of global share, anchoring overall demand within its home region throughout the forecast period.
• Intense M&A activity is reshaping the competitive landscape, as leading diagnostics providers integrate specialized testing platforms to create comprehensive, value-driven solutions for the expanding companion animal healthcare sector.
• Pet humanization, coupled with a surge in chronic and age-related companion animal diseases, fundamentally drives the accelerating adoption of advanced, preventative diagnostic testing solutions across global veterinary practices.
• The rapid integration of advanced point-of-care diagnostics and AI-driven analytical platforms is profoundly transforming veterinary medicine, demanding adaptive regulatory responses and accelerating diagnostic innovation across the industry.
• The burgeoning demand for genetic screening and early disease detection presents significant strategic opportunities in developed markets, necessitating tailored product development and distribution strategies to capture emerging pet owner preferences.
• Robust venture capital investment continues to fuel innovation in specialized companion animal diagnostics, while resilient supply chain strategies are critical for meeting escalating global demand and advancing R&D breakthroughs.
• The market’s forward trajectory anticipates sustained expansion, underpinned by converging technological innovations, proactive regulatory alignment, and deeper integration with holistic veterinary health management ecosystems globally.
Key Market Takeaways
Critical findings and data points from this market research study.
Base Year Valuation
The Companion Testing Technologies Market was valued at $684.1 million in the base year, reflecting its foundational market size.
Robust Growth Outlook
The market is projected to experience substantial growth, expanding at a Compound Annual Growth Rate (CAGR) of 9.5% through the forecast period.
Future Market Scale
By the forecast year, the Companion Testing Technologies Market is anticipated to reach a valuation of $1.7 billion, indicating significant expansion.
Regional Leadership
North America is expected to remain a dominant region in the market, driven by high pet ownership rates and advanced veterinary infrastructure.
Advancing Diagnostics Trend
A notable trend in this market is the increasing adoption of advanced point-of-care diagnostic technologies for rapid and accurate results in companion animal healthcare.
Key Growth Drivers
Market expansion is fueled by rising pet ownership, growing consumer expenditure on pet healthcare, and an increasing emphasis on early disease detection and preventive care for companion animals.
Market Dynamics
Market Trends
- Increasing demand for point-of-care diagnostics in clinics.
- Growing adoption of non-invasive testing methods for pets.
- Rising interest in genetic testing for breed-specific conditions.
- Integration of digital health platforms for remote monitoring.
Growth Drivers
- Rising pet humanization and increased pet ownership globally.
- Growing awareness among pet owners about preventative care.
- Advancements in veterinary diagnostic technologies and accuracy.
- Increasing disposable income spent on premium pet healthcare.
Restraints
- High costs of advanced tests limit adoption by many pet owners.
- Lack of awareness among pet owners hinders market expansion.
- Slow integration of new technologies by veterinary practices is a challenge.
- Regulatory hurdles and lengthy approval processes can delay market entry.
Opportunities
- Developing advanced AI-powered diagnostic solutions for accuracy.
- Expanding market penetration in emerging economies with pets.
- Offering personalized medicine approaches for companion animals.
- Innovating in early disease detection and chronic disease management.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Point-Of-Care Diagnostic TestsIn-House Laboratory AnalyzersMolecular Diagnostic PlatformsReference Laboratory ServicesDiagnostic Imaging ModalitiesAnatomical Pathology ServicesData Management & Software Solutions |
| By Technology | ImmunoassayMolecular DiagnosticsClinical ChemistryHematologyUrinalysisRadiographyUltrasonographyCytology & Histopathology Techniques |
| By Application | Infectious Disease DiagnosisParasitic Disease DiagnosisAllergy & Dermatology TestingCancer & Oncology DiagnosticsEndocrine System TestingRenal & Hepatic Function MonitoringGenetic Health ScreeningPre-Surgical Screening & Wellness Panels |
| By End-User | Veterinary Reference LaboratoriesVeterinary Hospitals & ClinicsAcademic Veterinary InstitutesAnimal Welfare Organizations & SheltersSpecialty Veterinary PracticesPharmaceutical & Animal Health CompaniesPrivate Diagnostic Laboratories |
| By Component | Diagnostic InstrumentsReagents & AssaysConsumables & DisposablesSoftware & InformaticsService & Support |
| By Deployment | Centralized Laboratory DeploymentIn-Clinic Benchtop DeploymentPoint-Of-Care Mobile DeploymentCloud-Based Software DeploymentOn-Premise Software Deployment |
Regional Analysis
- North America leads the companion testing technologies market, driven by high pet adoption rates, strong veterinary care spending, and advanced diagnostic infrastructure. Significant R&D investment and a willingness among pet owners to pay for sophisticated health screening further bolster its dominant position.
- Asia-Pacific is projected as the fastest-growing region, fueled by increasing disposable incomes, a burgeoning middle class, and rising pet adoption, particularly in emerging economies. Growing awareness about pet health and the expansion of veterinary clinics also contribute significantly to this rapid growth.
- In Europe, a notable trend is the increasing integration of digital health solutions and point-of-care testing within veterinary clinics. This focuses on enhancing diagnostic efficiency and accessibility, driven by technological advancements and a demand for more immediate and convenient pet healthcare services.
| North AmericaXX.X% | EuropeXX.X% | Asia PacificXX.X% | Latin AmericaXX.X% | Middle East & AfricaXX.X% |
North America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- North America holds the largest market share due to high pet ownership rates, advanced veterinary infrastructure, and significant disposable income allocated to pet healthcare.
- The region benefits from established companion animal diagnostic companies and a strong culture of preventive pet care.
Latin America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Latin America demonstrates considerable market growth, driven by an expanding pet ownership base and a gradual improvement in veterinary care standards, particularly in countries like Brazil and Mexico.
- Increasing awareness regarding animal health and preventive care is a key factor.
Europe
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Europe represents a substantial market, driven by a strong pet-owning population, increasing awareness of pet health, and well-developed veterinary services across countries like Germany, the UK, and France.
- Regulatory support for animal health products also contributes to its stability.
Asia Pacific
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- The Asia Pacific region is experiencing rapid growth, fueled by rising pet adoption rates, increasing disposable incomes, and urbanization in key economies such as China, India, and Japan.
- This growth is also spurred by improving veterinary standards and accessibility to diagnostic technologies.
Middle East & Africa
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- This region is an evolving market for companion testing technologies, showing growth in urban areas and increasing awareness of companion animal health.
- While starting from a smaller base, investments in veterinary infrastructure and pet ownership are on the rise in several countries.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | US$ XX.X Mn | XX.X% | The U.S. leads with a vast pet-owning population, high disposable income, and advanced veterinary infrastructure, driving significant demand for companion diagnostic technologies. |
| 2 | Brazil | US$ XX.X Mn | XX.X% | Brazil represents a significant market with the largest pet population in Latin America, urbanization, and a growing middle class increasingly investing in pet health and diagnostics. |
| 3 | Germany | US$ XX.X Mn | XX.X% | Germany's market is strong due to its large pet population, high animal welfare standards, and advanced veterinary medical facilities that readily adopt new diagnostic technologies. |
| 4 | China | US$ XX.X Mn | XX.X% | China is experiencing explosive growth in pet ownership and veterinary services, fueled by rising disposable incomes and urbanization, making it a high-potential market for companion testing. |
| 5 | Saudi Arabia | US$ XX.X Mn | XX.X% | Saudi Arabia's market for companion animal testing is expanding due to rising pet ownership, high disposable incomes, and the modernization of its veterinary healthcare services. |
Countries Covered (26)
United States, Canada, Mexico, Brazil, Argentina, Rest of Latin America, Germany, United Kingdom, France, Italy, Spain, Russia, Rest of Europe, China, Japan, South Korea, Australia, India, Taiwan, New Zealand, Malaysia, Rest of Asia Pacific, Saudi Arabia, South Africa, United Arab Emirates, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Heska | XX.X% | Focus on high-value diagnostic and specialty products for companion animals, expanding through direct sales and strategic partnerships. | — | — | Element CT5Element HT5Element RCX+1 |
| 2 | Virbac | XX.X% | Provide a comprehensive range of animal health products, from prevention to treatment and diagnostics, leveraging a global presence. | — | — | MilbemaXEffiproCaniVax+1 |
| 3 | Neogen Corporation | XX.X% | Develop and market diagnostic solutions for food and animal safety, expanding capabilities through strategic acquisitions and technology integration. | — | — | ANSRGeneSeekAccuPoint+1 |
| 4 | Bio-Rad Laboratories | XX.X% | Provide innovative life science research and clinical diagnostic products by focusing on advanced technology and global market reach. | — | — | QX200 Droplet Digital PCR SystemChemiDoc XRS+ZE5 Cell Analyzer+1 |
| 5 | Horiba | XX.X% | Deliver precision measurement and analytical systems across various industries, including medical diagnostics, leveraging advanced Japanese technology. | — | — | Yumizen H500ABX Pentra XL 80HORIBA Medical+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Heska, Virbac, Neogen Corporation, Bio-Rad Laboratories, Horiba, Sysmex, Biomerieux, Mindray, Ceva Sante Animale, Randox Laboratories, DiaSys Diagnostic Systems, Eurofins Scientific, Woodley Equipment Company, ID.vet, VMRD Inc., DRG International, Globalvet Diagnostics, MEDILAB Global, Anogen Animal Health, Immunostics
The global Companion Testing Technologies market features a competitive landscape led by Heska, Virbac, Neogen Corporation, Bio-Rad Laboratories, Horiba, and Sysmex, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on company revenue disclosures and public sources; undisclosed figures are marked.
Company Profiles
Heska
Virbac
Neogen Corporation
Bio-Rad Laboratories
Horiba
Sysmex
Biomerieux
Mindray
Ceva Sante Animale
Randox Laboratories
DiaSys Diagnostic Systems
Eurofins Scientific
Woodley Equipment Company
ID.vet
VMRD Inc.
DRG International
Globalvet Diagnostics
MEDILAB Global
Anogen Animal Health
Immunostics
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
Global Leader Launches AI-Powered POC Diagnostic Platform for Pets
VetDiag Solutions, a prominent name in animal health diagnostics, unveiled its 'PetSense AI' platform, integrating rapid point-of-care testing with artificial intelligence for enhanced diagnostic accuracy and efficiency across multiple companion animal conditions. This innovation promises faster results and more informed treatment plans for veterinarians.
AniHealth Corp. Acquires PetGeneDx, Bolstering Genetic Testing Portfolio
AniHealth Corporation announced the acquisition of PetGeneDx, a biotech startup specializing in advanced genetic diagnostics for hereditary diseases and cancer predisposition in companion animals. This strategic move is expected to significantly expand AniHealth's molecular diagnostics offerings and R&D capabilities.
VetLab Networks Partners with University for Novel Biomarker Discovery
Leading veterinary laboratory network, GlobalVet Labs, has established a multi-year partnership with the University of Animal Sciences' Veterinary Research Center to develop and validate novel biomarkers for early detection of feline chronic kidney disease. This collaboration aims to bring new diagnostic tools to market, improving early intervention for a widespread pet health issue.
Pet Diagnostics Innovator Secures US$ XX.X Investment for Portable Devices
MobileVet Diagnostics, a company focused on bringing laboratory-grade testing to any veterinary setting, closed a US$ XX.X Series B funding round led by Animal Health Ventures. The investment will accelerate the development and market expansion of their next-generation portable diagnostic devices, designed for remote and emergency animal care.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $684.1 Mn |
| Market Size (Forecast) | $1.7 Bn |
| CAGR | 9.5% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 26 Countries |
| Segments Covered | 6 Segments, 40 Sub-segments |
| Companies Profiled | 32 Companies |
Report Value
Why Choose This Report
Complete Market Size
Market sizing for the base year and a 10-year forecast across three scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data for every country in the report scope, across all major regions.
Company Profiles
Profiles of the leading companies, with disclosed financials, strategy and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Strategic Analysis · Management Insights · CXO Insights
Executive Strategic & Intelligence Report
A board-ready strategic deck built on the Companion Testing Technologies Market report: eleven chapters and an appendix, from market sizing to the board decisions, delivered as a PDF with an Excel datapack. US$3,000 per market, prepared after your order.
What to expect in the Executive Report for this market
- About 400 slides, 11 chapters and an appendix. Built on this report's own numbers, so every figure matches the report and the Excel.
- Market size and forecast to 2035. By segment, sub-segment, region and country, with conservative, base and optimistic cases.
- An analysis page after every exhibit. The key insight, ten specific points and the decision it implies for leaders, challengers, entrants and investors.
- Competitive intelligence. Shares and positioning, capability benchmark, strategies, recent moves and acquisition screening.
- Customers, technology and business models. Who buys and why, AI and technology impact, pricing, channels and go-to-market by segment.
- Risks and scenarios. Risk register, four future scenarios with signposts, and early-warning indicators with thresholds.
- Opportunities and the board decisions. Opportunity scoring, strategic options, roadmap, capability gaps, decision matrix and a 90-day plan.
- PDF, Excel datapack and PowerPoint. A bookmarked PDF, the full Excel datapack and editable infographic slides for your own decks.
US$3,000 per market · bought online, prepared after your order and emailed to you
See a full example report →Only need the headline view? Market Snapshot (PDF) + Excel Datasheet · 10–20 slide PDF + Excel
A CEO-level executive summary of the market in 10–20 slides - size and forecast, growth by segment and region, the leading countries and companies, key trends and the outlook - plus the Excel datasheet. A short executive view of this market, not the full analysis - PDF and Excel, prepared and emailed to you after your order.
Trusted by strategy teams, investors & global enterprises
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The Companion Testing Technologies market is estimated at $684.1 Mn in 2025. It is forecast to reach $1.7 Bn by 2035, indicating substantial growth over the forecast period. These figures reflect the total market value.
The Companion Testing Technologies market is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.5% from 2025 to 2035. This growth rate reflects the anticipated expansion of the market over the next decade.
The market is segmented by Type, Technology, Application, End-User, Component, and Deployment. Key segments include Point-Of-Care Diagnostic Tests, Molecular Diagnostics, Infectious Disease Diagnosis, Veterinary Reference Laboratories, Diagnostic Instruments, and Centralized Laboratory Deployment.
Leading companies in this market include Heska, Virbac, Neogen Corporation, Bio-Rad Laboratories, Horiba, Sysmex, Biomerieux, Mindray, Ceva Sante Animale, Randox Laboratories, DiaSys Diagnostic Systems, and Eurofins Scientific. These companies contribute to the market's development and offerings.
The Companion Testing Technologies market report provides a comprehensive analysis of market size, growth drivers, and restraints. It also covers emerging opportunities, market segmentation by various criteria, and the competitive landscape, including profiles of leading companies.
The Single User and Enterprise licences include the full PDF report, the PowerPoint (PPT), the Excel data workbook and the interactive Online Dashboard. The Online Dashboard gives online access to the snapshot and datasheet with export features, and the Market Snapshot is an executive summary in PDF with the Excel data sheet.
Yes. Request a free report preview: its scope, every chapter and what it contains, the methodology and the headline figures. The full report is a paid product.
We accept credit/debit cards (Visa, Mastercard, Amex), bank wire transfer, and purchase orders for enterprise clients. All transactions are secured with 256-bit SSL encryption.
Buy This Report
Choose the format that fits your budget
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
Strategic deck for this market
Executive Strategic & Intelligence Report
About 400 board-ready slides: every exhibit with its analysis and the decision it implies. Prepared for this market after your order and emailed to you.
Need to go deeper?
Intelligence services for this market
- Competitor benchmarking →
- Market entry & expansion →
- Product & growth opportunities →
- Investment & acquisition due diligence →
What's Included
Similar Reports
Point-of-Care Molecular Testing Market
$3.4 Bn in 2025 · 7.5% CAGR
Advanced Molecular Diagnostics Market
$14.6 Bn in 2025 · 16.2% CAGR
AI Diagnostics Market
$2.1 Bn in 2025 · 16.3% CAGR
AI Echocardiography Market
$300.0 Mn in 2025 · 20.3% CAGR
AI Genomic Diagnostics Market
$800.1 Mn in 2025 · 24.0% CAGR
AI Histology Market
$386.1 Mn in 2025 · 20.5% CAGR
AI in Radiology Market
$1.2 Bn in 2025 · 18.4% CAGR
AI Kidney Disease Diagnostics Market
$214.0 Mn in 2025 · 18.8% CAGR